Stanislav Mičuda
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 39
- Drug Transport and Resistance Mechanisms 36
- Pharmacology 20
- Pharmacogenetics and Drug Metabolism 11
- Drug-Induced Hepatotoxicity and Protection 7
- Co-authors
- Milos Hroch (33 shared papers)Jolana Cermanová (33 shared papers)František Štaud (13 shared papers)Petr Pávek (20 shared papers)Petr Nachtigal (23 shared papers)Eva Doleželová (17 shared papers)Eva Brčáková (18 shared papers)Martina Čečková (4 shared papers)
- Journals
- Physiological Research (8 papers)Life Sciences (5 papers)Pharmacological Research (3 papers)Journal of Gastroenterology and Hepatology (3 papers)Frontiers in Pharmacology (3 papers)
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Stanislav Mičuda
96 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 112
- Pharmacology 195
- Oncology 452
- Biochemistry 92
- Obstetrics and Gynecology 68
- Hepatology 62
Countries citing papers authored by Stanislav Mičuda
This map shows the geographic impact of Stanislav Mičuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislav Mičuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislav Mičuda more than expected).
Fields of papers citing papers by Stanislav Mičuda
This network shows the impact of papers produced by Stanislav Mičuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislav Mičuda. The network helps show where Stanislav Mičuda may publish in the future.
Co-authors
The 25 scholars most cited alongside Stanislav Mičuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 83 | |
| 2 | 2011 | 59 | |
| 3 | 2013 | 59 | |
| 4 | 2012 | 50 | |
| 5 | 2004 | 47 | |
| 6 | 2005 | 45 | |
| 7 | 2007 | 45 | |
| 8 | 2015 | 43 | |
| 9 | 2010 | 41 | |
| 10 | 2008 | 40 | |
| 11 | 2012 | 37 | |
| 12 | 2017 | 36 | |
| 13 | 2012 | 36 | |
| 14 | 2017 | 35 | |
| 15 | 2010 | 34 | |
| 16 | 2013 | 31 | |
| 17 | 2009 | 30 | |
| 18 | 2020 | 27 | |
| 19 | 2012 | 27 | |
| 20 | 2015 | 26 |
About Stanislav Mičuda
Stanislav Mičuda is a scholar working on Oncology, Pharmacology, Biochemistry, Hepatology and Pediatrics, Perinatology and Child Health, having authored 98 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (36 papers), Liver Disease Diagnosis and Treatment (13 papers), Pharmacogenetics and Drug Metabolism (11 papers), Hormonal Regulation and Hypertension (7 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Pharmacological Effects and Toxicity Studies (6 papers), Mesenchymal stem cell research (6 papers) and Estrogen and related hormone effects (5 papers). The work is most often cited by research in Pharmacology (195 citations), Oncology (452 citations), Biochemistry (92 citations), Obstetrics and Gynecology (68 citations) and Hepatology (62 citations). Stanislav Mičuda has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Milos Hroch, Jolana Cermanová, František Štaud, Petr Pávek, Petr Nachtigal, Eva Doleželová, Eva Brčáková, Martina Čečková, Leoš Fuksa and Jaroslav Mokrý. Their work appears in journals such as Physiological Research, Life Sciences, Pharmacological Research, Journal of Gastroenterology and Hepatology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.